Dsuvia

Active Ingredient(s): Sufentanil
FDA Approved: * November 2, 2018
Pharm Company: * ACELRX PHARMA INC
Category: Pain Relief

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Dsuvia Overview

Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times more potent than its parent drug, fentanyl, and 500 times as potent as morphine. Structurally, sufentanil differs from fentanyl through the addition of a methoxymethyl group on the piperidine ring (which is believed to reduce duration of action[2]), and the replacement of the phenyl ring by thiophene. Sufentanil first was synthesized at Janssen Pharmaceu...

Read more Dsuvia Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sufentanil

Recent Dsuvia Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sufentanil
  • Injection: 0.05mg/ml, 50mcg/ml
  • Powder: 100%
  • Tablet: 0.03mg, 30mcg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Dsuvia: (1 result)

Sorted by National Drug Code
  • 61621-430 Dsuvia 30 ug/1 Sublingual Tablet by Acelrx Pharmaceuticals, Inc

Other drugs which contain Sufentanil or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA